120 related articles for article (PubMed ID: 11897413)
1. Transport and metabolism of opioid peptides across BeWo cells, an in vitro model of the placental barrier.
Ampasavate C; Chandorkar GA; Vande Velde DG; Stobaugh JF; Audus KL
Int J Pharm; 2002 Feb; 233(1-2):85-98. PubMed ID: 11897413
[TBL] [Abstract][Full Text] [Related]
2. [Application of BeWo cell model in studies on placental transport mechanism].
Guo J; Song DR
Zhongguo Zhong Yao Za Zhi; 2012 Nov; 37(21):3193-7. PubMed ID: 23397711
[TBL] [Abstract][Full Text] [Related]
3. Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier.
Gao B; Hagenbuch B; Kullak-Ublick GA; Benke D; Aguzzi A; Meier PJ
J Pharmacol Exp Ther; 2000 Jul; 294(1):73-9. PubMed ID: 10871297
[TBL] [Abstract][Full Text] [Related]
4. Uptake mechanism of valproic acid in human placental choriocarcinoma cell line (BeWo).
Ushigome F; Takanaga H; Matsuo H; Tsukimori K; Nakano H; Ohtani H; Sawada Y
Eur J Pharmacol; 2001 Apr; 417(3):169-76. PubMed ID: 11334847
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and secretion of human chorionic gonadotropin and its subunits in choriocarcinoma cells: a comparative study with normal placental cells.
Takeuchi Y; Sakakibara R; Ishiguro M
Mol Cell Endocrinol; 1990 Mar; 69(2-3):145-56. PubMed ID: 1691720
[TBL] [Abstract][Full Text] [Related]
6. Insulin enhancement of opioid peptide transport across the blood-brain barrier and assessment of analgesic effect.
Witt KA; Huber JD; Egleton RD; Davis TP
J Pharmacol Exp Ther; 2000 Dec; 295(3):972-8. PubMed ID: 11082431
[TBL] [Abstract][Full Text] [Related]
7. Efflux transporter mRNA expression profiles in differentiating JEG-3 human choriocarcinoma cells as a placental transport model.
Ikeda K; Yamasaki K; Homemoto M; Yamaue S; Ogawa M; Nakao E; Fukunaga Y; Nakanishi T; Utoguchi N; Myotoku M; Hirotani Y
Pharmazie; 2012 Jan; 67(1):86-90. PubMed ID: 22393837
[TBL] [Abstract][Full Text] [Related]
8. In vitro placental model optimization for nanoparticle transport studies.
Cartwright L; Poulsen MS; Nielsen HM; Pojana G; Knudsen LE; Saunders M; Rytting E
Int J Nanomedicine; 2012; 7():497-510. PubMed ID: 22334780
[TBL] [Abstract][Full Text] [Related]
9. Influence of peptidase inhibitors on the apparent agonist potency of delta selective opioid peptides in vitro.
Kramer TH; Toth G; Haaseth RC; Matsunaga TO; Davis P; Hruby VJ; Burks TF
Life Sci; 1991; 48(9):881-6. PubMed ID: 1847736
[TBL] [Abstract][Full Text] [Related]
10. Effect of size and charge on the passive diffusion of peptides across Caco-2 cell monolayers via the paracellular pathway.
Pauletti GM; Okumu FW; Borchardt RT
Pharm Res; 1997 Feb; 14(2):164-8. PubMed ID: 9090703
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization of L-alanine transport in a placental choriocarcinoma cell line (BeWo).
Moe AJ; Furesz TC; Smith CH
Placenta; 1994 Dec; 15(8):797-802. PubMed ID: 7886021
[TBL] [Abstract][Full Text] [Related]
12. Acyloxyalkoxy-based cyclic prodrugs of opioid peptides: evaluation of the chemical and enzymatic stability as well as their transport properties across Caco-2 cell monolayers.
Bak A; Gudmundsson OS; Friis GJ; Siahaan TJ; Borchardt RT
Pharm Res; 1999 Jan; 16(1):24-9. PubMed ID: 9950274
[TBL] [Abstract][Full Text] [Related]
13. Characterization of glucose transport and glucose transporters in the human choriocarcinoma cell line, BeWo.
Shah SW; Zhao H; Low SY; Mcardle HJ; Hundal HS
Placenta; 1999 Nov; 20(8):651-9. PubMed ID: 10527819
[TBL] [Abstract][Full Text] [Related]
14. IGF regulation of neutral amino acid transport in the BeWo choriocarcinoma cell line (b30 clone): evidence for MAP kinase-dependent and MAP kinase-independent mechanisms.
Fang J; Mao D; Smith CH; Fant ME
Growth Horm IGF Res; 2006; 16(5-6):318-25. PubMed ID: 17035059
[TBL] [Abstract][Full Text] [Related]
15. In vitro transport mechanism of psoralen in a human placental cell line (BeWo cells).
Guo J; Song D; Han F; Zhang W; Wang Y; Wang Y; Du W
Planta Med; 2015 Jan; 81(2):138-44. PubMed ID: 25626141
[TBL] [Abstract][Full Text] [Related]
16. Assessment of stereoselectivity of trimethylphenylalanine analogues of delta-opioid [D-Pen(2),D-Pen(5)]-enkephalin.
Witt KA; Slate CA; Egleton RD; Huber JD; Yamamura HI; Hruby VJ; Davis TP
J Neurochem; 2000 Jul; 75(1):424-35. PubMed ID: 10854288
[TBL] [Abstract][Full Text] [Related]
17. Transport mechanisms for long-chain polyunsaturated fatty acids in the human placenta.
Dutta-Roy AK
Am J Clin Nutr; 2000 Jan; 71(1 Suppl):315S-22S. PubMed ID: 10617989
[TBL] [Abstract][Full Text] [Related]
18. Peptide transport and metabolism across the placenta.
Chandorkar GA; Ampasavate C; Stobaugh JF; Audus KL
Adv Drug Deliv Rev; 1999 Jun; 38(1):59-67. PubMed ID: 10837746
[TBL] [Abstract][Full Text] [Related]
19. Permeability properties of monolayers of the human trophoblast cell line BeWo.
Liu F; Soares MJ; Audus KL
Am J Physiol; 1997 Nov; 273(5):C1596-604. PubMed ID: 9374645
[TBL] [Abstract][Full Text] [Related]
20. Single residue modifications of the delta opioid receptor selective peptide, [D-Pen2,D-Pen5]-enkephalin (DPDPE). Correlation of pharmacological effects with structural and conformational features.
Haaseth RC; Sobczyk-Kojiro K; Medzihradsky F; Smith CB; Mosberg HI
Int J Pept Protein Res; 1990 Aug; 36(2):139-46. PubMed ID: 2177042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
